Disposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Model

Simple item page
dc.contributor.authorCochran, Michael C.
dc.contributor.authorEisenbrey, John R.
dc.contributor.authorSoulen, Michael C.
dc.contributor.authorSchultz, Susan M.
dc.contributor.authorOuma, Richard O.
dc.contributor.authorWhite, Sarah B.
dc.contributor.authorFurth, Emma E.
dc.contributor.authorWheatley, Margaret A.
dc.date.accessioned2022-08-31T15:20:22Z
dc.date.available2022-08-31T15:20:22Z
dc.date.issued2011
dc.description.abstractA doxorubicin-loaded microbubble has been developed that can be destroyed with focused ultrasound resulting in fragments, or “nanoshards” capable of escaping through the leaky tumor vasculature, promoting accumulation within the interstitium. This study uses a rat liver cancer model to examine the biodistribution and tumoral delivery of this microbubble platform compared with de novo drug-loaded polymer nanoparticles and free doxorubicin. Microbubbles (1.8 μm) and 217-nm nanoparticles were prepared containing 14-C labeled doxorubicin. Microbubbles, nanoparticles, a combination of the two, or free doxorubicin were administered intravenously in rats bearing hepatomas, concomitant with tumor insonation. Doxorubicin levels in plasma, organs, and tumors were quantified after 4 hours and 7 and 14 days. Tumors were measured on sacrifice and evaluated with autoradiography and histology. Animals treated with microbubbles had significantly lower plasma doxorubicin concentrations (0.466 ± 0.068%/mL) compared with free doxorubicin (3.033 ± 0.612%/mL, P = .0019). Drug levels in the myocardium were significantly lower in animals treated with microbubbles compared to free doxorubicin (0.168%/g tissue vs. 0.320%/g, P = .0088). Tumors treated with microbubbles showed significantly higher drug levels than tumors treated with free doxorubicin (2.491 ± 0.501 %/g vs. 0.373 ± 0.087 %/g, P = .0472). These tumors showed significantly less growth than tumors treated with free doxorubicin (P = .0390). Doxorubicin loaded microbubbles triggered with ultrasound provided enhanced, sustained drug delivery to tumors, reduced plasma and myocardium doxorubicin levels, and arresting tumor growth. The results suggest that in situ generation of nano particles provides a superior treatment over injection of free drug and also de novo synthesized nanoparticles.en_US
dc.identifier.citationCochran, M. C., Eisenbrey, J. R., Soulen, M. C., Schultz, S. M., Ouma, R. O., White, S. B., ... & Wheatley, M. A. (2011). Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. Academic radiology, 18(11), 1341-1348.https://doi.org/10.1016/j.acra.2011.06.013en_US
dc.identifier.issn1076-6332
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/4497
dc.language.isoenen_US
dc.publisherAcademic radiologyen_US
dc.subjectUltrasound contrast agent; targeted drug delivery; hepatocellular carcinoma; nanoparticlesen_US
dc.titleDisposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Modelen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Disposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Model.pdf
Size:
1.31 MB
Format:
Adobe Portable Document Format
Description:
Disposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Model
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences